Could a simple blood test track a deadly brain Tumor's return?
NCT ID NCT07398170
Summary
This study aims to see if cancer cells from aggressive, recurring brain tumors (meningiomas) can be found in a patient's blood or spinal fluid. Researchers will test samples from 15 adults whose tumors have come back after surgery. The goal is to learn if these 'liquid biopsies' could one day help doctors monitor the disease without repeated invasive procedures.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Montpellier
Montpellier, France, 34295, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.